AngioDynamics (ANGO) SVP Chad Campbell Receives Award, Sells Shares

What Happened
Chad Thomas Campbell, SVP & GM, Vascular Access at AngioDynamics, received 6,466 shares of common stock on July 22, 2026 upon settlement/vesting of performance share units (PSUs). To satisfy tax withholding, 2,330 of those shares were disposed at $13.82 per share for total withholding of $32,201. The PSU grant originally targeted 22,768 units; based on performance, 6,466 shares were issued and the remainder were forfeited.

Key Details

• Transaction date: July 22, 2026; Form 4 filed July 24, 2026 (appears timely).
• Issued/Acquired: 6,466 shares @ $0.00 (settlement of PSUs; code M for conversion).
• Disposed/Withheld: 2,330 shares @ $13.82 for tax withholding (code F) — proceeds/withholding = $32,201.
• Net shares retained from this vesting: 4,136 shares (6,466 issued minus 2,330 withheld).
• Original award: target of 22,768 PSUs granted July 19, 2023; payout was 6,466 based on multi-year performance metrics, remainder forfeited (see footnote).
• Filing did not disclose total shares beneficially owned after the transaction in the provided data.

Context
This was a compensation-related settlement of performance-based equity (not an open-market buy or voluntary sale). The disposal of shares was a routine tax-withholding action rather than a discretionary market sale. For derivative/PSU transactions, the important points are how many units vested, how many were paid out, and how many were withheld for taxes — which are all noted above.